Member Info for RayPointer

I hope Eccles knows what time it is

So why has a DNA non-personalised vaccine been included?

Do all VAL employees post on here?

"Cohorts 3 and 4 are a desperate attempt to extract some value from iscib1+ which has extended patent life. Except avidimab if you check the mechanism of action has nothing to do with activating t cells in the way iscib1+ is supposed to be doing."

Immunobody's main feature is the dual presentation of both the DNA plasmid and antibodies to the APC. The antibodies being produced by the soft muscle cells.

Scancell have always been keen to point out that it is the dual presentation that is responsible for the high avidity of the activated TCells and it is also responsible for the high level of clonal expansion. Single presentation either by the DNA plasmid or antibodies produces TCells of nowhere near the same avidity and with weaker clonal expansion.

Perhaps the presence of avidimab on the antibodies increases the probability of an APC cell being penetrated by both the DNA plasmid and the antibody (with the help of avidimab).

Just a thought.

The 25p was the current analyst consensus, not a SP prediction

He also seems to be a very canny bloke businesswise.

Sorry remove "don't" from my last post 😂

It was always Lindy's aspiration that SC134 be developed in house.

I don't think this is less a change of tactics and more a confirmation that Lindy's wish is to be granted

"Looks like it's fingers crossed for a 2pm RNS !"

Most unlikely, sorry

Botski

There already is an iScib2+ developed some time ago but still awaiting clinical trials

Long suffering parents

HAGW everyone.

Things may be hotting up for us.

Don't tell the Fonz😂

I'm missing him already😂

But I'm sure he will return

VD, I think UXM is a definite contender for being chief moaner 😂

Here's scinv hard at work

https://cdn.welcometothejungle.co/uploads/article/social_image/3943/158341/large_linkedin-clavier-1.jpg

Except that the level of tariffs Trump is applying to other countries are not based on the tariffs applied by that country to the US

Instead they are based on the trade surplus that country has with the US.

Perhaps the post was AI generated and the strong correlation between news dropping and price dropping was recognised.

It's a shame LSE don't provide a 50% tariff button

Https://www.bing.com/videos/riverview/relatedvideo?q=what%20have%20the%20romans%20ever%20done%20for%20us&mid=5F5462C4664ADEBE1F855F5462C4664ADEBE1F85&ajaxhist=0

😂

I see your point but not so long ago we could have said the exact same thing about Genmab